Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
M
038290
vs
K
KOSPI 200
Over the past 12 months, Macrogen Inc has underperformed KOSPI 200, delivering a return of -28% compared to KOSPI 200's +62% growth.
Stocks Performance
038290 vs KOSPI 200
Performance Gap
038290 vs KOSPI 200
Performance By Year
038290 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Macrogen Inc
Glance View
Macrogen Inc. is a genomics company that helps researchers and hospitals read and analyze DNA. It offers gene sequencing, genetic testing, and related lab services that turn biological samples into useful data. Its customers are mostly pharmaceutical companies, research institutes, hospitals, and other life science organizations that need accurate genetic information for research or diagnosis. The company makes money by charging for laboratory testing, sequencing, and data analysis services, and in some cases by supplying related research tools and products. A customer sends in a sample, Macrogen processes it in its labs, and then returns the results and interpretation. This makes the company a service provider in the middle of the genomics value chain rather than a drug maker or a hospital. What makes Macrogen different is that it sits at the intersection of laboratory science and digital data. It does not just run tests; it also helps customers interpret large amounts of genetic information. That role gives it a steady place in healthcare research, biotech development, and precision medicine, where accurate DNA data is often the starting point for new discoveries and treatment decisions.